Blog | Gen Re

Our Perspective

Synthesis Analysis - A Robust Statistical Tool for Life Insurance Underwriting and Pricing Research

By L/H North America - Decision Analytics Team|January 25, 2018|English

Application questions, health interviews, motor vehicle records, attending physician statements, paramedical exams, blood and urine tests, and prescription histories are common elements of the life insurance underwriting assessment process. This standard...
Read More
Treating Ageing to Extend a Healthy Lifespan

By Beata Puls |December 20, 2017|English

Life expectancy has increased remarkably in the last few decades. The number of people living to or even beyond age 100 is expected to increase. This puts ageing at centre stage alongside healthy life expectancy – meaning the years an ageing person...
Read More
Stroke in Younger Adults - Have Improvements Reached Their Limit?

By Dr. Chris Ball |December 18, 2017|English

Age remains the most consistent risk factor for ischaemic stroke. Surprisingly then an estimated 10% of diagnoses are now seen in people below the age of 50. In many countries vigorous management of vascular risk coupled to improved stroke services...
Read More
Lump Sum Benefits - The Experience in New Zealand

By Li Wen Beh and Winncy Wong |November 28, 2017|English

Read More
Progress in the Management of Multiple Sclerosis

By Dr. Chris Ball |November 23, 2017|English

Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course. MS is a covered condition in “Critical Illness” insurance policies sold in markets across Asia, in the UK and Ireland, South Africa, New Zealand...
Read More
Genetic Testing and the Power of Knowledge

By Annika Tiedemann |November 16, 2017|English

Using genetic testing to make treatment decisions on serious medical conditions, such as cancer, is becoming more common. Approved tests number in the thousands, and the costs associated with genome sequencing have fallen sharply. Most genetic tests...
Read More